Previsioni di mercato della nutrizione parenterale per l\'Asia Pacifico fino al 2030 - Analisi regionale - per tipo di nutriente (soluzione di aminoacidi a dose singola, emulsione lipidica parenterale, carboidrati, oligoelementi, vitamine e minerali) e utente finale (ospedali, cliniche e altri)

BMIRE00030378 | Pages: 95 | Pharmaceuticals | Jul 2024 | Type: Regional | Status: Published
Il mercato della nutrizione parenterale nell’Asia del Pacifico è stato valutato a 861,59 milioni di dollari nel 2022 e si prevede che raggiungerà 1.471,33 milioni di dollari entro il 2030; si stima registrerà un CAGR del 6,9% dal 2022 al 2030.

Gli sviluppi di nuovi prodotti da parte delle aziende stimolano il mercato della nutrizione parenterale nell\'Asia del Pacifico.

Le aziende che operano nel mercato della nutrizione medica parenterale si concentrano costantemente su nuove lanci di prodotti, che li aiutano a migliorare le vendite. Di seguito sono menzionati alcuni degli sviluppi degni di nota nel mercato della nutrizione parenterale:

Nel 2023, Baxter Korea ha lanciato Olimel N12E, un fluido per nutrizione parenterale totale (TPN) ricco di proteine per pazienti critici.

Nel 2023, JW Holdings ha iniziato a esportare Winuf Central 736/1.085 ml, una nutrizione parenterale totale (TPN) a tre camere, su larga scala in Mongolia tramite AsiaPharma LLC, un\'azienda farmaceutica locale.

Pertanto, si prevede che lo sviluppo di nuovi prodotti nutrizionali creerà opportunità per la crescita del mercato durante il periodo di previsione.

Panoramica del mercato della nutrizione parenterale nell\'Asia del Pacifico

La Cina si trova ad affrontare un\'elevata incidenza di cancro allo stomaco a causa della crescente prevalenza dell\'infezione da H. pylori tra la popolazione. Uno studio (2021) dell\'Agenzia internazionale per la ricerca sul cancro (IARC) dell\'Organizzazione mondiale della sanità e di istituzioni partner nel Regno Unito e in Cina ha rilevato che l\'infezione da H. pylori è prevalente in Cina. Inoltre, l’infezione da H. pylori è stata la causa principale del 62,1% dei casi di cancro gastrico cardiaco e del 78,5% dei casi di cancro gastrico non cardiaco tra gli adulti di età superiore ai 30 anni. Questo studio della IARC ha stimato che ogni anno in Cina si verificano circa 340.000 casi di cancro gastrico dovuti a infezione da H. pylori. Secondo lo studio Global Burden of Diseases pubblicato nell’ottobre 2020, il cancro allo stomaco è stato tra le prime 10 cause di morte nel 2019. Allo stesso modo, secondo gli ultimi dati dell’Agenzia internazionale per la ricerca sul cancro (IARC), l’incidenza stimata standardizzata per età Il tasso di cancro allo stomaco in Cina è di 20,58 per 100.000 e il tasso grezzo è di 33,06. Secondo la stessa fonte, il numero stimato di nuovi casi (di età compresa tra 0 e 74 anni) nel 2020 per entrambi i sessi è stato di 478.508. Pertanto, a causa dei fattori sopra menzionati, è probabile che il mercato della nutrizione parenterale registrerà una notevole crescita in Cina durante il periodo di previsione.

Entrate e previsioni del mercato della nutrizione parenterale nell\'Asia Pacifico fino al 2030 (milioni di dollari)

Segmentazione del mercato della nutrizione parenterale nell\'Asia Pacifico

Il mercato della nutrizione parenterale nell\'Asia Pacifico è segmentato in base ai nutrienti tipo, utente finale e paese. In base al tipo di nutriente, il mercato della nutrizione parenterale nell’Asia del Pacifico è classificato in soluzione di aminoacidi a dose singola, emulsione lipidica parenterale, carboidrati, oligoelementi e vitamine e minerali. Il segmento delle soluzioni di aminoacidi a dose singola ha detenuto la quota di mercato maggiore nel 2022.

In base all\'utente finale, il mercato della nutrizione parenterale nell\'Asia del Pacifico è segmentato in ospedali, cliniche e altri. Il segmento ospedaliero deteneva la quota di mercato maggiore nel 2022.

In base al paese, il mercato della nutrizione parenterale nell\'Asia Pacifico è segmentato in Cina, Giappone, India, Australia, Corea del Sud e resto dell\'Asia Pacifico. La Cina ha dominato la quota di mercato della nutrizione parenterale nell\'Asia del Pacifico nel 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd e Vifor Pharma Management AG sono alcuni dei principali attori che operano nel mercato della nutrizione parenterale nell\'Asia del Pacifico.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rise in Prevalence of Gastrointestinal Diseases

4.1.2 Surge in Cases of Malnutrition and Premature Births

4.2 Market Restraints

4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems

4.3 Market Opportunities

4.3.1 New Product Developments by Companies

4.4 Future Trends

4.4.1 Innovation in Formulations of Nutrition Products

4.5 Impact Analysis

5. Parenteral Nutrition Market - Asia Pacific Market Analysis

5.1 Overview

5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview

6.2 Single Dose Amino Acid Solution

6.2.1 Overview

6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Parenteral Lipid Emulsion

6.3.1 Overview

6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Carbohydrates

6.4.1 Overview

6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Trace Elements

6.5.1 Overview

6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vitamins and Minerals

6.6.1 Overview

6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Parenteral Nutrition Market Analysis - by End User

7.1 Overview

7.2 Hospitals

7.2.1 Overview

7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Clinics

7.3.1 Overview

7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Parenteral Nutrition Market - Country Analysis

8.1 Asia Pacific

8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country

8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.1 Overview

8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User

8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.1 Overview

8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User

8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.1 Overview

8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User

8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.1 Overview

8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User

8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.5.1 Overview

8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User

8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.6.1 Overview

8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type

8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview

9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Grifols SA

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Pfizer Inc

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Otsuka Pharmaceuticals Co Ltd

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Baxter International Inc

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 B Braun SE

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Fresenius Kabi AG

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Vifor Pharma Management AG

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 Aculife Healthcare Pvt Ltd

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Products and Services

10.10.4 Financial Overview

10.10.5 SWOT Analysis

10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. Parenteral Nutrition Market Segmentation

Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type

Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market

Table 15. Glossary of Terms, Parenteral Nutrition Market

List of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country

Figure 2. Parenteral Nutrition Market: Key Industry Dynamics

Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints

Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)

Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)

Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)

Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)

1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd 
9. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10. Vifor Pharma Management AG

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific parenteral nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific parenteral nutrition market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440